---
figid: PMC9898571__41392_2023_1330_Fig3_HTML
figtitle: 'Osteoarthritis: pathogenic signaling pathways and therapeutic targets'
organisms:
- NA
pmcid: PMC9898571
filename: 41392_2023_1330_Fig3_HTML.jpg
figlink: /pmc/articles/PMC9898571/figure/Fig3/
number: F3
caption: Activated Wnt canonical and non-canonical signaling pathways in OA. In healthy
  articular cartilage, the Wnt signaling pathway in articular cartilage and synovium
  is profoundly inhibited by the absence of Wnt-Wnt receptor interactions and β-catenin
  degradation through the proteasome pathway. In OA chondrocytes and synovial membrane
  cells, Wnt ligands bind to Frizzled/LRP5/6 receptors to activate the canonical pathway,
  in which the destruction complex moves to the cell membrane and releases β-catenin
  to translocate to the nucleus and binding with TCF/LEF family to control target
  gene transcription. For the non-canonical Wnt pathway, the protein kinase C (PKC)
  and c-Jun N-terminal Kinase (JNK) are activated to upregulate downstream target
  genes and pathways, including the calcium pathway
papertitle: 'Osteoarthritis: pathogenic signaling pathways and therapeutic targets.'
reftext: Qing Yao, et al. Signal Transduct Target Ther. 2023;8:56.
year: '2023'
doi: 10.1038/s41392-023-01330-w
journal_title: Signal Transduction and Targeted Therapy
journal_nlm_ta: Signal Transduct Target Ther
publisher_name: Nature Publishing Group UK
keywords: Rheumatic diseases | Senescence | Molecular medicine
automl_pathway: 0.9397212
figid_alias: PMC9898571__F3
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC9898571__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9898571__41392_2023_1330_Fig3_HTML.html
  '@type': Dataset
  description: Activated Wnt canonical and non-canonical signaling pathways in OA.
    In healthy articular cartilage, the Wnt signaling pathway in articular cartilage
    and synovium is profoundly inhibited by the absence of Wnt-Wnt receptor interactions
    and β-catenin degradation through the proteasome pathway. In OA chondrocytes and
    synovial membrane cells, Wnt ligands bind to Frizzled/LRP5/6 receptors to activate
    the canonical pathway, in which the destruction complex moves to the cell membrane
    and releases β-catenin to translocate to the nucleus and binding with TCF/LEF
    family to control target gene transcription. For the non-canonical Wnt pathway,
    the protein kinase C (PKC) and c-Jun N-terminal Kinase (JNK) are activated to
    upregulate downstream target genes and pathways, including the calcium pathway
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK8
  - MAPK9
  - MAPK10
  - FRZB
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - TPI1
  - ARHGEF5
  - TIMELESS
  - HAVCR1
  - CTNNB1
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - HNF4A
  - LEF1
  - TCF7
  - TCF7L1
  - TCF7L2
  - LRP6
  - LRP5
  - SNX9
  - RUNX2
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - TP53
  - TP63
  - TP73
  - MMP13
---
